IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
äŒæ¥ã³ãŒãIRIX
äŒç€ŸåIRIDEX Corp
äžå Žæ¥Feb 16, 1996
æé«çµå¶è²¬ä»»è
ãCEOãMercer (Patrick)
åŸæ¥å¡æ°93
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 16
æ¬ç€Ÿæåšå°1212 Terra Bella Ave
éœåžMOUNTAIN VIEW
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94043
é»è©±çªå·16509404700
ãŠã§ããµã€ãhttps://www.iridex.com/
äŒæ¥ã³ãŒãIRIX
äžå Žæ¥Feb 16, 1996
æé«çµå¶è²¬ä»»è
ãCEOãMercer (Patrick)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã